Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression.
Kandasamy, Kathirvel
Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression. [electronic resource] - Shock (Augusta, Ga.) Jul 2011 - 76-82 p. digital
Publication Type: Journal Article
1540-0514
10.1097/SHK.0b013e31821a4002 doi
Animals
Atorvastatin
Enzyme Inhibitors--pharmacology
Guanylate Cyclase--antagonists & inhibitors
Heptanoic Acids--therapeutic use
Mice
Nitric Oxide--metabolism
Norepinephrine--adverse effects
Oxadiazoles--pharmacology
Polymerase Chain Reaction
Pyrroles--therapeutic use
Quinoxalines--pharmacology
RNA, Messenger
Receptors, Adrenergic, alpha-1--genetics
Sepsis--drug therapy
Vasoconstrictor Agents--adverse effects
Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression. [electronic resource] - Shock (Augusta, Ga.) Jul 2011 - 76-82 p. digital
Publication Type: Journal Article
1540-0514
10.1097/SHK.0b013e31821a4002 doi
Animals
Atorvastatin
Enzyme Inhibitors--pharmacology
Guanylate Cyclase--antagonists & inhibitors
Heptanoic Acids--therapeutic use
Mice
Nitric Oxide--metabolism
Norepinephrine--adverse effects
Oxadiazoles--pharmacology
Polymerase Chain Reaction
Pyrroles--therapeutic use
Quinoxalines--pharmacology
RNA, Messenger
Receptors, Adrenergic, alpha-1--genetics
Sepsis--drug therapy
Vasoconstrictor Agents--adverse effects